RELAPSED ADULT AML
Clinical trials for RELAPSED ADULT AML explained in plain language.
Never miss a new study
Get alerted when new RELAPSED ADULT AML trials appear
Sign up with your email to follow new studies for RELAPSED ADULT AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on tough leukemia in early trial
Disease control Recruiting nowThis early-stage trial tests a new treatment called CLL-1 CAR-NK cells for adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified to better recognize and attack leukemia cells. Th…
Matched conditions: RELAPSED ADULT AML
Phase: PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 26, 2026 08:29 UTC
-
New drug cocktail offers hope for tough leukemia cases
Disease control Recruiting nowThis study tests a combination of three drugs (venetoclax, chidamide, and azacitidine) in 30 adults whose acute myeloid leukemia has returned or not responded to standard treatment. The goal is to see if this mix can safely help more patients achieve remission. Participants must …
Matched conditions: RELAPSED ADULT AML
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Experimental CAR-T therapy targets stubborn leukemia in small safety trial
Disease control Recruiting nowThis early-phase study tests whether a type of immunotherapy called CD19 CAR-T cells is safe for adults with a hard-to-treat form of acute myeloid leukemia (AML) that has returned or not responded to standard treatments. The therapy uses a patient's own immune cells, modified in …
Matched conditions: RELAPSED ADULT AML
Phase: PHASE1 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated May 19, 2026 11:59 UTC